X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (59) 59
humans (59) 59
aged (47) 47
middle aged (45) 45
oncology (41) 41
adult (33) 33
obstetrics & gynecology (32) 32
index medicus (30) 30
cancer (27) 27
ovarian cancer (22) 22
aged, 80 and over (21) 21
article (18) 18
chemotherapy (17) 17
ovarian neoplasms - drug therapy (16) 16
carcinoma (14) 14
neoplasm staging (14) 14
care and treatment (13) 13
research (12) 12
obstetrics and gynecology (11) 11
prognosis (11) 11
disease-free survival (10) 10
hematology, oncology and palliative medicine (10) 10
analysis (9) 9
neurosciences (9) 9
ovarian neoplasms - pathology (9) 9
psychiatry (9) 9
allergy and immunology (8) 8
cisplatin (8) 8
combined modality therapy (8) 8
immunology (8) 8
oncology, experimental (8) 8
therapy (8) 8
treatment outcome (8) 8
uterine cervical neoplasms - pathology (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
drug administration schedule (7) 7
expression (7) 7
neoplasm recurrence, local - drug therapy (7) 7
ovarian neoplasms - metabolism (7) 7
paclitaxel - administration & dosage (7) 7
paclitaxel - adverse effects (7) 7
peritoneal neoplasms - drug therapy (7) 7
proportional hazards models (7) 7
retrospective studies (7) 7
risk factors (7) 7
stress (7) 7
animals (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
breast-cancer (6) 6
carboplatin - administration & dosage (6) 6
clinical trials (6) 6
depression (6) 6
endometrial neoplasms - pathology (6) 6
ovarian neoplasms - psychology (6) 6
social support (6) 6
survival (6) 6
trial (6) 6
women (6) 6
adenocarcinoma - pathology (5) 5
angiogenesis (5) 5
antineoplastic agents - therapeutic use (5) 5
carcinoma, ovarian epithelial (5) 5
cervical cancer (5) 5
circadian rhythm (5) 5
cytokines (5) 5
endometrial neoplasms - surgery (5) 5
health aspects (5) 5
ovarian neoplasms - mortality (5) 5
ovarian neoplasms - surgery (5) 5
paclitaxel (5) 5
surgery (5) 5
survival analysis (5) 5
survival rate (5) 5
tumors (5) 5
abridged index medicus (4) 4
age factors (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
antineoplastic agents - adverse effects (4) 4
carboplatin - adverse effects (4) 4
carcinoma, squamous cell - pathology (4) 4
cells (4) 4
cisplatin - administration & dosage (4) 4
cohort studies (4) 4
endometrial cancer (4) 4
endothelial growth-factor (4) 4
infusions, intravenous (4) 4
interleukin-6 (4) 4
kaplan-meier estimate (4) 4
male (4) 4
medical colleges (4) 4
mice (4) 4
neoplasms, glandular and epithelial - drug therapy (4) 4
norepinephrine (4) 4
ovarian neoplasms - blood (4) 4
ovarian neoplasms - complications (4) 4
prospective studies (4) 4
quality-of-life (4) 4
radiotherapy (4) 4
uterine neoplasms - pathology (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2012, Volume 366, Issue 7, pp. 610 - 618
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2010, Volume 28, Issue 16, pp. 2727 - 2731
Journal Article
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 07/2019, Volume 154, Issue 1, p. 13
To determine if the addition of paclitaxel (P) to cisplatin and doxorubicin (CD) following surgical debulking and volume-directed radiation therapy improved... 
Anthracyclines | Relapse | Endometrial cancer | Patient outcomes | Oncology, Experimental | Radiation | Research | Diseases | Chemotherapy | Operating systems | Analysis | Diagnosis | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e40312
Endometrial carcinoma is the most common gynecologic cancer, yet the mechanisms underlying this disease process are poorly understood. We hypothesized that... 
METHYL-N-NITROSOUREA | SIGNALING PATHWAY | MICROSATELLITE INSTABILITY | COLORECTAL-CANCER | MULTIDISCIPLINARY SCIENCES | CYCLIN D1 GENE | OVARIAN CARCINOMAS | BETA-CATENIN EXPRESSION | ESTROGEN-RECEPTOR | EPITHELIAL-MESENCHYMAL INTERACTIONS | MATRIX METALLOPROTEINASE-7 | Cyclin D1 - metabolism | Cell Proliferation | Adenocarcinoma - chemically induced | Humans | Lymphoid Enhancer-Binding Factor 1 - genetics | Middle Aged | Endometrial Neoplasms - metabolism | Endometrial Neoplasms - chemically induced | Male | Adenocarcinoma - metabolism | Gene Expression Regulation, Developmental | Methylnitrosourea | Lymphoid Enhancer-Binding Factor 1 - physiology | Aged, 80 and over | Adult | Female | Endometrium - metabolism | Mice, Inbred C57BL | Endometrium - growth & development | Lymphoid Enhancer-Binding Factor 1 - metabolism | Mice, Inbred ICR | Mice, Knockout | Animals | Cyclin D1 - genetics | Cell Transformation, Neoplastic | Aged | Mice | Endometrium - pathology | Estrous Cycle - metabolism | Endometrial cancer | Comparative analysis | Neonates | Glands | Colorectal cancer | Biology | Estrus cycle | Cyclin D1 | Carcinogenesis | Carcinogens | Uterus | Animal tissues | Lining (process) | Tumorigenesis | Localization | Endometrium | Estrus | Menstruation | Gynecology | Obstetrics | Regeneration | LEF-1 protein | Mutation | Uterine cancer | Tumors | Cancer | Matrilysin
Journal Article
Ear and Hearing, ISSN 0196-0202, 05/2019, p. 1
OBJECTIVES:During the past decade, the initial popularity of metal-on-metal (MoM) hip implants has shown a progressive decline due to increasingly reported... 
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2008, Volume 112, Issue 3, pp. 543 - 552
Journal Article
International Journal of Nursing Studies, ISSN 0020-7489, 2009, Volume 46, Issue 6, pp. 804 - 812
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2015, Volume 53, pp. 256 - 267
Journal Article